Cellular Anti-Wrinkle SunScreen SPF 30La Prarie (La Prairie Group AG)
Welcome to the PulseAid listing for the Cellular Anti-Wrinkle SunScreen SPF 30 drug offered from La Prairie Group AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | La Prairie Group AG |
NON-PROPRIETARY NAME: | Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone |
SUBSTANCE NAME: | AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2009-01-01 |
END MARKETING DATE: | 0000-00-00 |
Cellular Anti-Wrinkle SunScreen SPF 30 La Prarie HUMAN OTC DRUG Details:
Item Description | Cellular Anti-Wrinkle SunScreen SPF 30 La Prarie from La Prairie Group AG |
LABELER NAME: | La Prairie Group AG |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 7.5; 2.6; 2.4; 5(g/100mL; g/100mL; g/100mL; g/100mL; g/100mL) |
START MARKETING DATE: | 2009-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76157-411_6c00012f-f7e2-4fc3-87d2-2e79f3b079db |
PRODUCT NDC: | 76157-411 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE Pharmaceutical Manufacturers / Labelers: